A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)

Clinical trial NCT02145026 · COMPLETED

Trial details

NCT number: NCT02145026
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2014-08-06
Primary completion: 2019-04-09
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.